0001193125-26-116123
SEC filingLeonaBio, Inc. stockholders approved at a Special Meeting the 2026 Equity Incentive Plan reserving up to 5,700,000 shares (plus up to 1,300,000 recycled from the 2020 Plan, which terminated for future grants), issuances of common stock upon exercises of pre-funded warrants by Sermonix Pharmaceuticals, Inc. and warrants by Perceptive Advisors LLC, and an amendment increasing authorized common shares from 90,000,000 to 400,000,000. The Certificate of Amendment was filed March 18, 2026.